A Pilot Study on Diabetes Distress, Insulin Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and HbA1c in Diabetic Patients

Tahiruddin Tahiruddin; Diah Indriastuti; Syahrul Syahrul; Andi Masyitha Irwan; Satriya Pranata

doi:10.14710/nmjn.v15i1.58052

DOI: https://doi.org/10.14710/nmjn.v15i1.58052

A Pilot Study on Diabetes Distress, Insulin Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and HbA1c in Diabetic Patients

*Tahiruddin Tahiruddin

- Sekolah Tinggi Ilmu Kesehatan (STIKes) Karya Kesehatan, Indonesia

Diah Indriastuti

- Bachelor of Nursing Study Program, Faculty of Medicine, Halu Oleo University, Indonesia

Syahrul Syahrul

- Department of Community and Family Health Nursing, Faculty of Nursing, Universitas Hasanuddin, Indonesia

Andi Masyitha Irwan

- Department of Community and Family Health Nursing, Faculty of Nursing, Universitas Hasanuddin, Indonesia

Satriya Pranata

- Department of Nursing, Faculty of Nursing and Health Sciences, Universitas Muhammadiyah Semarang, Indonesia

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

BibTex Citation Data :

@article{NMJN58052,
    author = {Tahiruddin Tahiruddin and Diah Indriastuti and Syahrul Syahrul and Andi Irwan and Satriya Pranata},
    title = {A Pilot Study on Diabetes Distress, Insulin Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and HbA1c in Diabetic Patients},
    journal = {Nurse Media Journal of Nursing},
  volume = {15},
    number = {1},
    year = {2025},
    keywords = {Diabetes; HbA1c; IGF-I; IGFBP-3},
    abstract = {  Background:  Diabetes distress refers to the emotional and psychological burden experienced by individuals in managing their condition, which can influence physiological outcomes and overall well-being. However, the relationship between HbA1c, insulin growth factor-I (IGF-I), and insulin-like growth factor binding protein-3 (IGFBP-3) with diabetes distress in diabetic patients remains elusive.     Purpose:  The objective of this study was to evaluate the association of IGF-I, IGFBP-3, and HbA1c with diabetes distress in diabetic patients.   Methods:  A cross-sectional design with purposive sampling was used to recruit subjects from the public health center in Kendari City, Southeast Sulawesi, Indonesia, from May to November 2021. A total of 30 diabetic patients were recruited. Distress data were collected using the Indonesian version of the Diabetes Distress Scale (DDS) questionnaire. HbA1c levels were measured using High-Performance Liquid Chromatography (HPLC). Serum levels of IGF-I and IGFBP-3 were measured using the ELISA (Enzyme-Linked Immunosorbent Assay) kit method. The data were analyzed using regression analysis.   Results:  Most respondents had moderate distress, with a DDS score of 53.4%, high IGF-I levels in 76.7%, and low IGFBP-3 levels in 76.7%. As many as 60% of respondents had an HbA1c level above 6.4%. IGF-I (ρ-value = 0.024) and IGFBP-3 levels (ρ-value = 0.042) were significantly correlated with diabetes distress. However, HbA1c levels were not significantly correlated with diabetes distress (ρ-value = 0.155).   Conclusion:  IGF-I and IGFBP-3 levels were associated with diabetes distress, but HbA1c was not. Patients with higher distress were found to have elevated serum levels of IGF-I and IGFBP-3. Future research should focus on stress management strategies that support efforts to prevent disease and complications associated with diabetes mellitus. },
   issn = {2406-8799},  doi = {10.14710/nmjn.v15i1.58052},
    url = {https://ejournal.undip.ac.id/index.php/medianers/article/view/58052}
}

Citation Format:

Abstract

Background: Diabetes distress refers to the emotional and psychological burden experienced by individuals in managing their condition, which can influence physiological outcomes and overall well-being. However, the relationship between HbA1c, insulin growth factor-I (IGF-I), and insulin-like growth factor binding protein-3 (IGFBP-3) with diabetes distress in diabetic patients remains elusive.

Purpose: The objective of this study was to evaluate the association of IGF-I, IGFBP-3, and HbA1c with diabetes distress in diabetic patients.

Methods: A cross-sectional design with purposive sampling was used to recruit subjects from the public health center in Kendari City, Southeast Sulawesi, Indonesia, from May to November 2021. A total of 30 diabetic patients were recruited. Distress data were collected using the Indonesian version of the Diabetes Distress Scale (DDS) questionnaire. HbA1c levels were measured using High-Performance Liquid Chromatography (HPLC). Serum levels of IGF-I and IGFBP-3 were measured using the ELISA (Enzyme-Linked Immunosorbent Assay) kit method. The data were analyzed using regression analysis.

Results: Most respondents had moderate distress, with a DDS score of 53.4%, high IGF-I levels in 76.7%, and low IGFBP-3 levels in 76.7%. As many as 60% of respondents had an HbA1c level above 6.4%. IGF-I (ρ-value = 0.024) and IGFBP-3 levels (ρ-value = 0.042) were significantly correlated with diabetes distress. However, HbA1c levels were not significantly correlated with diabetes distress (ρ-value = 0.155).

Conclusion: IGF-I and IGFBP-3 levels were associated with diabetes distress, but HbA1c was not. Patients with higher distress were found to have elevated serum levels of IGF-I and IGFBP-3. Future research should focus on stress management strategies that support efforts to prevent disease and complications associated with diabetes mellitus.

Fulltext

Keywords: Diabetes; HbA1c; IGF-I; IGFBP-3

Funding: Ministry of Education and Culture, Republic of Indonesia

Article Metrics:

Article Info

Section: Articles

Language : EN

In Vol 15, No 1 (2025): (April 2025) (in progress)

Recent articles

Home Health Care Nurses' Challenges in Implementing Person-Centered Care among Elderly Patients with Dementia The Role of Parents and Environmental Conditions on the Incidence of Malaria in School-Age Children in East Sumba Regency, Indonesia A Pilot Study on Diabetes Distress, Insulin Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and HbA1c in Diabetic Patients More recent articles

Most cited articles

Self-Efficacy Affects Cancer Patients in Solving Problems, Seeking Support and Avoiding Problems as Coping Mechanisms The Quality of Life of Women with Cervical Cancer in Indonesia: A Cross-Sectional Study Nurses’ Patient Safety Competencies in Aceh Province, Indonesia Back-matter The Lived Experience of PLWHA and Partner’s Responses toward the Fulfillment of Sexual Needs More cited articles

Abdlwhab, H. M., Al-saffar, A., Mahdi, O. A., & Alameri, R. B. (2024). The impact of insulin resistance and glycaemic control on insulin-like growth factor-1 in patients with type 2 diabetes : a cross- sectional study. Clinical Diabetes and Endocrinology, 10(36). https://doi.org/https://doi.org/10.1186/s40842-024-00202-8
Aguirre, G. A., Ita, J. R., Garza, R. G. de la, & Castilla-Cortazar, I. (2016). Insulin-like growth factor-1 deficiency and metabolic syndrome. Journal of Translational Medicine, 14(3), 1–23. https://doi.org/10.1186/s12967-015-0762-z
Aljuaid, M. O., Almutairi, A. M., Assiri, M. A., Almalki, D. M., & Alswat, K. (2018). Diabetes-related distress assessment among type 2 diabetes patients. Journal of Diabetes Research, 2018(1). https://doi.org/10.1155/2018/7328128
AlOtaibi, A. A., Almesned, M., Alahaideb, T. M., Almasari, S. M., & Alsuwayt, S. S. (2021). Assessment of diabetes‑related distress among type 2 diabetic patients, Riyadh, Saudi Arabia. Journal of Family Medicine and Primary Care, 10(3481–9). https://doi.org/10.4103/jfmpc.jfmpc
Alves-Bezerra, M., & Cohen, D. E. (2019). Triglyceride metabolism in the liver. Comprehensive Physiology, 8(1), 1–22. https://doi.org/10.1002/cphy.c170012
American Diabetes Association. (2020). Standards of medical care in diabetes―2020. The Journal of Clinical and Applied Research and Educational and Applied : Diabetes Care, 43(1), S98–S110. https://doi.org/10.2337/dc20-S009
Aneke-Nash, C. S., Parrinello, C. M., Rajpathak, S. N., Rohan, T. E., Strotmeyer, E. S., Kritchevsky, S. B., Psaty, B. M., Bůžková, P., Kizer, J. R., Newman, A. B., Strickler, H. D., & Kaplan, R. C. (2015). Changes in insulin-like growth factor-I and its binding proteins are associated with diabetes mellitus in older adults. Journal of the American Geriatrics Society, 63(5), 902–909. https://doi.org/10.1111/jgs.13390
Arifin, B., Asselt, A. D. I. Van, Setiawan, D., Atthobari, J., Postma, M. J., & Cao, Q. (2019). Diabetes Distress in Indonesian Patients with Type 2 Diabetes : A Comparison Between Primary and Tertiary Care. BMC Health Services Research, 19(773), 1–11
Arifin, B., Perwitasari, D. A., Thobari, J. A., Cao, Q., Krabbe, P. F. M., & Postma, M. J. (2017). Translation, Revision, and Validation of the Diabetes Distress Scale for Indonesian Type 2 Diabetic Outpatients with Various Types of Complications. Value in Health Regional Issues, 12, 63–73. https://doi.org/10.1016/j.vhri.2017.03.010
Baradaran, H. R., Mirghorbani, S.-M., Javanbakht, A., Yadollahi, Z., & Khamseh, M. E. (2013). Diabetes distress and its association with depression in patients with type 2 diabetes in iran. International Journal of Preventive Medicine, 4(5), 580–584. http://www.ncbi.nlm.nih.gov/pubmed/23930169
Batais, M. A., Alfraiji, A. F., Alyahya, A. A., Aloofi, O. A., Almashouq, M. K., Alshehri, K. S., Almizel, A. M., Alotaibi, M. T., & Alosaimi, F. D. (2021). Assessing the Prevalence of Diabetes Distress and Determining Its Psychosocial Predictors Among Saudi Adults With Type 2 Diabetes : A Cross-Sectional Study. Frontiers in Psychology, 12(759454), 1–12. https://doi.org/10.3389/fpsyg.2021.759454
Biadgo, B., Tamir, W., & Ambachew, S. (2020). Insulin-like growth factor and its therapeutic potential for diabetes complications-mechanisms and metabolic links: A review. Review of Diabetic Studies, 16(1), 24–34. https://doi.org/10.1900/RDS.2020.16.24
Botros, R. M., El-Sherbeeny, A. A. A., Barbary, N. S. El, Muhammed, A. M., & Ali, H. M. (2020). Study of the effect of nutrition and glycemic control and on IGF-1 and growth in pre-pubertal egyptian children with T1DM. Egyptian Journal of Hospital Medicine, 81(5), 2084–2087. https://doi.org/10.21608/EJHM.2020.126407
Chinedu, A. C., & Foluso, O. (2023). Diabetes Distress: The Untold Hidden Struggle of Living with Diabetes Mellitus. African Journal of Health, Nursing and Midwifery, 6(2), 99–111. https://doi.org/10.52589/ajhnm-98vrwpip
Clemmons, D. R. (2012). Metabolic Actions of IGF-I in Normal Physiology and Diabetes. Endocrinol Metab Clin North Am, 41(2), 235–242. https://doi.org/10.1007/978-3-642-23635-8_30
Clemmons, D. R. (2018). Role of igf-binding proteins in regulating igf responses to changes in metabolism. Journal of Molecular Endocrinology, 61(1), T139–T169. https://doi.org/10.1530/JME-18-0016
Drogan, D., Schulze, M. B., Boeing, H., & Pischon, T. (2016). Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor–Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC– Potsdam Study. American Journal of Epidemiology, 183(6), 553–560. https://doi.org/10.1093/aje/kwv188
Duggan, C., Wang, C., Neuhouser, M. L., Xiao, L., Smith, A. W., Reding, K. W., Richard, N., Baumgartner, K. B., Bernstein, L., Ballard-, R., & Mctiernan, A. (2014). Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer. 132(5), 1191–1200. https://doi.org/10.1002/ijc.27753.Associations
Elotla, S. F., Fouad, A. M., Mohamed, S. F., Joudeh, A. I., Mostafa, M., Hayek, S. El, Shah, J., & Ahmed, H. A. S. (2022). Association between diabetes-related distress and glycemic control in primary care patients with Type 2 diabetes during the coronavirus disease 2019 (COVID-19) pandemic in Egypt. Journal of Family and Community Medicine, 30(1), 42–50. https://doi.org/10.4103/jfcm.jfcm_238_22
Fraenkel, E., & Lazurova, I. (2023). IGF-1 and IGFBP3 as indirect markers of hepatic insulin resistance and their relation to metabolic syndrome parameters in liver steatosis patients. Endocrine Regulations, 57(1), 69–79. https://doi.org/10.2478/enr-2023-0009
Gedikli, M. A., Kalın, B. S., & Sivas, A. A. (2022). Relationship Between HbA1c Level and Triglyceride/HDL Cholesterol Ratio and Triglyceride Glucose Index in Diabetes Patients. Bagcilar Medical Bulletin, 7(1), 27–31. https://doi.org/10.4274/BMB.galenos.2022.2021.09.095
Harris, M. L., Oldmeadow, C., Hure, A., Luu, J., Loxton, D., & Attia, J. (2017). Stress increases the risk of type 2 diabetes onset in women: A 12-year longitudinal study using causal modelling. PLOS ONE, 12(2), 1–13. https://doi.org/10.1371/journal.pone.0172126
Hatting, M., Tavares, C. D. J., Sharabi, K., Rines, A. K., & Puigserver, P. (2018). Insulin regulation of gluconeogenesis. Annals of the New York Academy of Sciences, 1411(1), 21–35. https://doi.org/10.1111/nyas.13435
Hilliard, M. E., Yi-Frazier, J. P., Hessler, D., Butler, A. M., Anderson, B. J., & Jaser, S. (2016). Stress and A1c Among People with Diabetes Across the Lifespan. Curr Diab Rep, 16(8), 139–148. https://doi.org/10.1007/s11892-016-0761-3.Stress
Hu, Y., Li, L., & Zhang, J. (2020). Diabetes Distress in Young Adults with Type 2 Diabetes: A Cross-Sectional Survey in China. Journal of Diabetes Research, 2020, 6–8. https://doi.org/10.1155/2020/4814378
International Diabetes Federation. (2019). IDF Diabetes Atlas: Ninth Edition 2019 (9th ed.). International Diabetes Federation
Jeong, M., & Reifsnider, E. (2018). Associations of Diabetes- Related Distress and Depressive Symptoms With Glycemic Control in Korean Americans With Type 2 Diabetes. The Diabetes Educator, 44(6). https://doi.org/10.1177/0145721718807443
Joseph, J. J., & Golden, S. H. (2018). Cortisol Dysregulation: The Bidirectional Link Between Stress, Depression, and Type 2 Diabetes Mellitus Joshua. Ann N Y Acad Sci, 1391(1). https://doi.org/10.1111/nyas.13217
Kalra, S., Jena, B. N., & Yeravdekar, R. (2018). Emotional and psychological needs of people with diabetes. Indian Journal of Endocrinology and Metabolism, 22(5), 696–704. https://doi.org/10.4103/ijem.IJEM_579_17
Kasprzak, A. (2021). Insulin-like growth factor 1 (Igf-1) signaling in glucose metabolism in colorectal cancer. International Journal of Molecular Sciences, 22(12). https://doi.org/10.3390/ijms22126434
Kim, S.-H., & Park, M.-J. (2017). Effects of growth hormone on glucose metabolism and insulin resistance in human. Annals of Pediatric Endocrinology & Metabolism, 22(3), 145–152. https://doi.org/10.6065/apem.2017.22.3.145
Kim, S. Y., Kim, M., Oh, Y., & Lee, D. Y. (2021). Relationship of Serum Total Insulin-Like Growth Factor Binding Protein-3 with Insulin-Like Growth Factor-I and Glucose Tolerance in Korean Children and Adolescents. International Journal of Endocrinology, 2021. https://doi.org/10.1155/2021/9966114
Klop, B., Elte, J. W. F., & Cabezas, M. C. (2013). Dyslipidemia in Obesity: Mechanisms and Potential Targets. Nutrients, 5(4), 1218–1240. https://doi.org/10.3390/nu5041218
Kristaningrum, N. D., Ramadhani, D. A., Hayati, Y. S., & Setyoadi. (2021). Correlation between the burden of family caregivers and health statuof people with diabetes mellitus. Journal of Public Health Research, 10(2), 326–331. https://doi.org/10.4081/jphr.2021.2227
Liu, B., & Wang, Y. (2024). Predictive value of IGF-1/IGFBP-3 ratio for thyroid nodules in type 2 diabetic mellitus. Frontiers in Endocrinology, 15(October), 1–10. https://doi.org/10.3389/fendo.2024.1444279
NeamŢu, M. C., Avramescu, E. T., Marcu, I. R., Turcu-Ştiolică, A., Boldeanu, M. V., NeamŢu, O. M., Tudorache, Ş., & Dănciulescu Miulescu, R. E. (2017). The correlation between insulin-like growth factor with glycemic control, glomerular filtration rate, blood pressure, hematological changes or body mass index in patients with type 2 diabetes mellitus. Romanian Journal of Morphology and Embryology = Revue Roumaine de Morphologie et Embryologie, 58(3), 857–861. http://www.ncbi.nlm.nih.gov/pubmed/29250665
Oguni, K., Yamamoto, K., Nakano, Y., Soejima, Y., Suyama, A., Takase, R., Yasuda, M., Hasegawa, K., & Otsuka, F. (2024). Trends of correlations between serum levels of growth hormone and insulin-like growth factor-I in general practice. Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1381083
Önal, Z. E., Atasayan, V., Akici, N., Gürbüz, T., & Nuhoglu, Ç. (2014). The Relationship between Glycosylated Haemoglobin (HbA1c) Levels and Serum Lipid Profiles in Insulin Resistant Children. Hong Kong Journal of Paediatrics, 19(1), 22–27
Pankiv, V. I., & Yuzvenko, T. Y. (2023). The relationships between variables of glycated hemoglobin and diabetes distress in patients with type 1 and type 2 diabetes mellitus. Miznarodnij Endokrinologicnij Zurnal, 19(6), 424–427. https://doi.org/10.22141/2224-0721.19.6.2023.1310
Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mullan, J., & Jackson, R. A. (2005). Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care, 28(3), 626–631. https://doi.org/10.2337/diacare.28.3.626
Pratiwi, P., Amatiria, G., & Yamin, M. (2014). Pengaruh Stress Terhadap Kadar Gula Darah Sewaktu Pada Pasien Diabetes Melitus Yang Menjalani Hemodialisa. Jurnal Kesehatan, 5(1), 11–16. https://doi.org/https://doi.org/10.26630/jk.v5i1.59
Ramkisson, S. (2017). Social Support and Coping in Adults with Type 2 Diabetes. African Journal of Primary Health Care & Family Medicine, 9(1), 1–8. https://doi.org/https://doi. org/10.4102/phcfm. v9i1.1405 Copyright:
Ranke, M. B. (2015). Insulin-like growth factor binding-protein-3 (IGFBP-3). Best Practice and Research: Clinical Endocrinology and Metabolism, 29(5), 701–711. https://doi.org/10.1016/j.beem.2015.06.003
Sandler, C. N., & McDonnell, M. E. (2022). The role of hemoglobin A1c in the assessment of diabetes and cardiovascular risk. Cleveland Clinic Journal of Medicine, 83(1), 4–10. https://doi.org/10.3949/ccjm.83.s1.02
Sapra, A., & Bhandari, P. (2023). Diabetes. StatPearls Publishing LLC. https://www.ncbi.nlm.nih.gov/books/NBK551501/
Schnell, O., Crocker, J. B., & Weng, J. (2017). Impact of HbA1c Testing at Point of Care on Diabetes Management. Journal of Diabetes Science and Technology, 11(3). https://doi.org/10.1177/1932296816678263
Setia, M. S. (2016). Methodology series module 3: Cross-sectional studies. Indian Journal of Dermatology, 61(3), 261–264. https://doi.org/10.4103/0019-5154.182410
Sherwani, S. I., Khan, H. A., Ekhzaimy, A., Masood, A., & Sakharkar, M. K. (2016). Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomarker Insights, 11, 95–104. https://doi.org/10.4137/Bmi.s38440
Similä, M. E., Kontto, J. P., Virtamo, J., Hätönen, K. A., & Valsta, L. M. (2019). Insulin-like growth factor I , binding proteins -1 and -3 , risk of type 2 diabetes and macronutrient intakes in men. British Journal OfNutrition, 121, 938–944. https://doi.org/10.1017/S0007114519000321
Skinner, T. C., Joensen, L., & Parkin, T. (2020). Twenty-five years of diabetes distress research. Diabetic Medicine, 37(3), 393–400. https://doi.org/10.1111/dme.14157
Stoop, C., Pouwer, F., Pop, V., Oudsten, B. Den, & Nefs, G. (2019). Psychosocial Health Care Needs of People with Type 2 Diabetes in Primary Care : Views of Patients and Health Care Providers. Journal of Advanced Nursing, 75, 1702–1712. https://doi.org/10.1111/jan.13996
Thau, L., Gandhi, J., & Sharma, S. (2023). Physiology, Cortisol. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK538239/
Vasilkova, V. N., Mokhort, T. V., Pchelin, I. Y., Bayrasheva, V. K., Naumenko, E. P., Korotaeva, L. E., & Filiptsova, N. A. (2021). Association between serum insulin like growth factor-1 (IGF-1) and insulin-like growth factor-binding protein-3 levels and chronic kidney disease in diabetic patients. Journal of Renal Injury Prevention, 10(1), 1–6. https://doi.org/10.34172/jrip.2021.05
Vedantam, D., Poman, D. S., Motwani, L., Asif, N., Patel, A., & Anne, K. K. (2022). Stress-Induced Hyperglycemia: Consequences and Management. Cureus, 1(7), 1–13. https://doi.org/10.7759/cureus.26714
Wang, X., & Cheng, Z. (2020). Cross-Sectional Studies: Strengths, Weaknesses, and Recommendations. Chest, 158(1S), S65–S71. https://doi.org/10.1016/j.chest.2020.03.012
Wei, L., Liping, Z., & Suya, K. (2023). Expression of insulin-like growth factor binding protein-3 in HELLP syndrome. BMC Pregnancy and Childbirth, 23(1), 1–17. https://doi.org/10.1186/s12884-023-06074-7
Wennberg, A. M. V, Hagen, C. E., Machulda, M. M., Hollman, J. H., Roberts, R. O., Knopman, D. S., Petersen, R. C., & Mielke, M. M. (2018). The association between peripheral total IGF-1, IGFBP-3, and IGF-1/IGFBP-3 and functional and cognitive outcomes in the Mayo Clinic Study of Aging. Neurobiology of Aging, 66, 68–74. https://doi.org/https://doi.org/10.1016/j.neurobiolaging.2017.11.017
Wibowo, Z. K., Wibisono, S., & Khairina. (2022). The relationship between diabetes distress and HbA1C level in type 2 diabetes mellitus therapy patients: a systematic review. Bali Medical Journal, 11(1), 476–484. https://doi.org/10.15562/bmj.v11i1.2986
Young-Hyman, D., De Groot, M., Hill-Briggs, F., Gonzalez, J. S., Hood, K., & Peyrot, M. (2016). Psychosocial care for people with diabetes: A position statement of the American diabetes association. Diabetes Care, 39(12), 2126–2140. https://doi.org/10.2337/dc16-2053
Young, B. M. O. E. E., Okafor, C. B. N. C. I., & Ugwueze, C. V. (2020). Diabetes Distress and Associated Factors in Patients with Diabetes Mellitus in South East Nigeria. Dubai Diabetes Endocrinol Journal, 26(31), 31–37. https://doi.org/10.1159/000508706
Zamani-Alavijeh, F., Araban, M., Koohestani, H. R., & Karimy, M. (2018). The effectiveness of stress management training on blood glucose control in patients with type 2 diabetes. Diabetology and Metabolic Syndrome, 10(1), 1–9. https://doi.org/10.1186/s13098-018-0342-5
Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023). The crucial role and mechanism of insulin resistance in metabolic disease. Frontiers in Endocrinology, 14(1149239). https://doi.org/10.3389/fendo.2023.1149239

Last update:

No citation recorded.

Last update: 2025-05-24 01:12:47

No citation recorded.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Journal Author(s) Rights

In order for the Department of Nursing, Faculty of Medicine, Universitas Diponegoro to publish and disseminate research articles, we need non-exclusive publishing rights (transferred from the author(s) to the publisher). This is determined by a publishing agreement between the author(s) and the Department of Nursing, Faculty of Medicine, Universitas Diponegoro. This agreement involves the transfer or licensing of the copyright for publishing to the publisher, while authors still retain significant rights to use and share their own published articles. The Department of Nursing, Faculty of Medicine, Universitas Diponegoro supports the need for authors to share, disseminate, and maximize the impact of their research through these rights in any databases.

As the author(s), you have rights to a wide range of uses of your article, including use by your employing institution or company. These author rights can be exercised without the need to obtain specific permission. Authors publishing in the Nurse Media Journal of Nursing have extensive rights to use their works for teaching and scholarly purposes without needing to seek permission, including:

use for classroom teaching by the author or the author’s institution and presentation at a meeting or conference, including distributing copies to attendees;
use for internal training by the author’s company;
distribution to colleagues for their research use;
use in a subsequent compilation of the author’s works;
inclusion in a thesis or dissertation;
reuse of portions or extracts from the article in other works (with full acknowledgment of the final article);
preparation of derivative works (other than for commercial purposes) (with full acknowledgment of the final article);
voluntary posting on open websites operated by the author or the author’s institution for scholarly purposes;

following the open access license of the Creative Commons CC BY-SA License.

Authors, readers, and third parties can copy and redistribute the material in any medium or format, as well as remix, transform, and build upon the material for any purpose, even commercially, but they must give appropriate credit (including the name of the creator and attribution parties, detailed information about the authors, a copyright notice, an open access license notice, a disclaimer notice, and a link to the material), provide a link to the license, and indicate if changes were made. The publisher will indicate any modification of the material (if any) and retain an indication of previous modifications using a CrossMark Policy and information about Erratum-Corrigendum notifications.

Authors, readers, and third parties can read, print, and download, redistribute or republish the article (e.g., display it in a repository), translate the article, download it for text and data mining purposes, reuse portions or extracts from the article in other works, sell or reuse it for commercial purposes, remix, transform, or build upon the material. They must distribute their contributions under the same license as the original Creative Commons Attribution-ShareAlike (CC BY-SA).

Copyright Transfer Agreement for Publishing (Publishing Right)

The Authors submitting a manuscript do so on the understanding that if accepted for publication, non-exclusive right for publishing (publishing right) of the article shall be assigned/transferred to Publisher of the Nurse Media Journal of Nursing (Department of Nursing, Faculty of Medicine, Universitas Diponegoro).

Upon acceptance of an article, authors will be asked to complete a 'Copyright Transfer Agreement for Publishing (CTAP)'. An e-mail will be sent to the Corresponding Author confirming receipt of the manuscript together with a 'Copyright Transfer Agreement for Publishing' form by online version of this agreement.

Nurse Media Journal of Nursing and Department of Nursing, Faculty of Medicine, Universitas Diponegoro, the Editors and the Editorial Board make every effort to ensure that no wrong or misleading data, opinions or statements be published in the journal. In any way, the contents of the articles and advertisements published in the Nurse Media Journal of Nursing are sole and exclusive responsibility of their respective authors and advertisers.

Please note that even though we ask for a transfer of copyright for publishing (CTAP), our journal Author(s) retain (or are granted back) significant scholarly rights as mentioned before.

The Copyright Transfer Agreement for Publishing (CTAP) Form can be downloaded here: [Copyright Transfer Agreement for Publishing (CTAP) Form NMJN 2024]

The copyright form should be signed electronically and send to the Editorial Office in the form of original e-mail below:

Dr. Meira Erawati (Editor-in-Chief)
Editorial Office of Nurse Media Journal of Nursing
Department of Nursing, Faculty of Medicine, Universitas Diponegoro
Jl. Prof. Soedarto, Tembalang, Semarang, Central Java, Indonesia 50275
Telp.: +62-24-76480919; Fax.: +62-24-76486849
E-mail: media_ners@live.undip.ac.id

(This policy statements has been updated at 24th January 2024)

A Pilot Study on Diabetes Distress, Insulin Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and HbA1c in Diabetic Patients

Journal Author(s) Rights

Copyright Transfer Agreement for Publishing (Publishing Right)

OFFICE INFORMATION